-
-
-
-
-
-
-
Veru Announces Proposed Public Offering
-
-
-
-
-
-
-
Veru, Inc. (VERU) Announces Positive Topline Data from Phase 2b QUALITY Clinical Study
-
-
-
-
-
-
-
Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the Worl
-
-
-
-
-
-
-
Form S-3 VERU INC.
-
-
-
-
-
-
-
Veru Announces Proposed Public Offering of Common Stock
-
-
-
-
-
-
71,803 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

